Glory, Audrey
Patocskai, Erica
Wong, Philip
Funding for this research was provided by:
Ministère de l'économie, de l'innovation et de l'énergie (MEIE), Québec, Canada (# 2021-2024-PSOv2d-55896, # 2021-2024-PSOv2d-55896)
Article History
Received: 4 September 2024
Accepted: 14 April 2025
First Online: 22 April 2025
Declarations
:
: This study was approved by the Research Ethics Board (REB) of the CHUM, REB-approved protocol 23.167. Subjects will provide written consent to participate after thorough discussion by signing the IRB-approved informed consent document.
: Not applicable (this manuscript does not contain data from any individual person).
: EP and PW are members of the Scientific advisory committee of NexPlasmaGen. AG has been an employee of NexPlasmaGen during the writing of this article. AG and PW are inventors on a pending patent co-owned by the CR-CHUM and NexPlasmaGen. PW is inventor on a patent co-owned by McGill University and NexPlasmaGen.